NEUROFEEDBACK MARKET REPORT OVERVIEW
- Request a Free Sample to learn more about this report
The global neurofeedback market size was USD 54 million in 2022 and the market is projected to touch USD 93.15 million by 2031, exhibiting a CAGR of 6.1% during the forecast period.
Neurofeedback, also known as EEG biofeedback or neurotherapy, is a therapeutic technique that involves real-time monitoring and feedback of a person's brain activity to help them learn to self-regulate their brain function. It is based on the idea that individuals can gain more control over their brain activity and, in turn, improve their cognitive, emotional, and behavioral functioning through this process.
During a neurofeedback session, electrodes or sensors are placed on a person's scalp to measure their brain's electrical activity, primarily through electroencephalography (EEG). The EEG data is then recorded and analyzed in real time. The recorded EEG data is processed by a computer, and specific aspects of the person's brain activity, such as brainwave patterns, are displayed in a visual or auditory format. This feedback is typically presented as a game, video, or sound, and it changes in response to the individual's brain activity. The individual is encouraged to consciously modify their brain activity in response to the feedback. The goal is to shift towards more desirable or balanced patterns of brainwave activity. For example, it can target specific brainwave frequencies associated with relaxation or focus.
COVID-19 Impact: Remote and Telehealth Services to Hinder Market Growth
The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.
The industry relies on specialized equipment and technology. Disruptions in the supply chain due to the pandemic could have led to delays in equipment manufacturing and distribution, affecting the availability of neurofeedback systems and devices. Many healthcare facilities, including those offering services, were strained by the influx of COVID-19 patients. This may have led to the temporary closure or reduced capacity of some clinics or treatment centers, affecting patient access to these services. To adapt to social distancing measures and lockdowns, some providers may have transitioned to offering remote or telehealth services. This could have affected the demand and delivery of neuro services, with potential implications for market dynamics.
LATEST TRENDS
"Personalized and Targeted Approaches to Drive Market Growth"
The COVID-19 pandemic accelerated the adoption of telehealth services, and this trend has likely continued in the field. More providers and clients are using remote monitoring and tele-neurofeedback, making services accessible to a broader population. Personalization of it’s protocols based on an individual's specific needs and brain patterns has been a growing trend. This approach enhances the effectiveness of neurofeedback interventions. Advances in EEG technology and software have improved the accuracy and ease of training. More user-friendly and portable systems have been developed.
NEUROFEEDBACK MARKET SEGMENTATION
- Request a Free Sample to learn more about this report
- By Type
Based on type the global market can be categorized into slow cortical potential neurofeedback (SCP-NF), low-energy neurofeedback system (LENS), Hemoencephalographic (HEG) neurofeedback and others.
Traditionally, slow cortical potential (SCP-NF) and LENS (low-energy system) have been more commonly used and researched compared to HEG (Hemoencephalographic). SCP-NF and LENS have a longer history of clinical application and scientific research supporting their effectiveness for various conditions.
- By Application
Based on application the global market can be categorized into ADHD treatment, another clinic uses and non-medical.
Neurofeedback has been widely used as a non-pharmacological approach to treating attention deficit hyperactivity disorder (ADHD). Many individuals, particularly parents of children with ADHD, seek as an alternative or complementary therapy to manage the condition. The demand for this treatment for ADHD treatment has been significant, driving neurofeedback market growth.
DRIVING FACTORS
"Advancements in Neuroimaging Technology to Augment the Market"
The increasing awareness and prevalence of mental health conditions, such as anxiety, depression, ADHD, and PTSD, are driving demand for non-pharmacological treatment options like neurofeedback. It is seen as a potential complementary or alternative therapy for these conditions. Advances in neuroscience and neuroimaging technologies have improved our understanding of the brain, making it more precise and effective. More sophisticated equipment and software have enhanced the accuracy and reliability of systems. A growing body of research supports the efficacy of neurofeedback for various applications. As scientific evidence accumulates, both clinicians and patients are becoming more confident in the effectiveness of neurofeedback as a therapeutic approach.
"Rising Interest in Peak Performance to Expand the Market"
Neurofeedback allows for personalized treatment plans, which can be tailored to the specific needs of individual patients. This personalization is attractive to both healthcare providers and patients seeking more targeted therapies. Beyond clinical applications, it is gaining popularity among individuals and athletes looking to enhance their cognitive and emotional performance. This interest in peak performance is expanding the market. The COVID-19 pandemic accelerated the adoption of telehealth and remote monitoring technologies. The providers have adapted to offer their services remotely, making treatment more accessible and convenient for patients. As stress and burnout become increasingly common in modern society, neurofeedback is being explored as a means of stress reduction and overall wellness.
RESTRAINING FACTOR
"High Cost to Potentially Impede Market Growth"
While there is a growing body of research supporting the efficacy of neurofeedback for various applications, some critics argue that the scientific evidence is not yet strong enough to fully validate its effectiveness for certain conditions. The need for more robust clinical trials and research can be a restraining factor. The equipment, sessions, and training can be relatively expensive. The cost can be a significant barrier for individuals seeking treatment, especially if it is not covered by insurance. There is a lack of standardized protocols and practices in the field of neurofeedback. The absence of universally accepted guidelines can lead to variations in treatment quality and effectiveness.
NEUROFEEDBACK MARKET REGIONAL INSIGHTS
- Request a Free Sample to learn more about this report
"North America to dominate the Market owing to Research and Development "
North America, has a well-established neurofeedback market share. It has a history of research and clinical applications, which has led to greater market maturity and acceptance. The United States is home to numerous research institutions and companies dedicated to the development and advancement of technologies and applications. This environment fosters innovation and drives market growth. There is a relatively high level of awareness about the equipment in North America. Many healthcare professionals and consumers are knowledgeable about the potential benefits of this therapy, which encourages its adoption.
KEY INDUSTRY PLAYERS
"Key Industry Players Shaping the Market through Innovation and Market Expansion"
The market is significantly influenced by key industry players that play a pivotal role in driving market dynamics and shaping consumer preferences. These key players possess extensive retail networks and online platforms, providing consumers with easy access to a wide variety of wardrobe options. Their strong global presence and brand recognition have contributed to increased consumer trust and loyalty, driving product adoption. Moreover, these industry giants continually invest in research and development, introducing innovative designs, materials, and smart features, catering to evolving consumer needs and preferences. The collective efforts of these major players significantly impact the competitive landscape and future trajectory of the market.
List of Market Players Profiled
- BrainMaster Technologies (U.S.)
- BEE Medic (Netherlands)
- Brainquiry (Netherlands)
- Mitsar (Russia)
- Thought Technology (Canada)
INDUSTRIAL DEVELOPMENT
2023, November: The industry relies heavily on specialized equipment, such as EEG machines and software. The continuous development and improvement of this technology have been instrumental in the growth of the market. This includes the development of more user-friendly, portable, and affordable equipment.
REPORT COVERAGE
The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.
The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 54 Million in 2021 |
Market Size Value By |
US$ 93.15 Million by 2031 |
Growth Rate |
CAGR of 6.1% from 2021 to 2031 |
Forecast Period |
2024-2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type & Application |
Frequently Asked Questions
-
What value is the neurofeedback market expected to touch by 2031?
The global neurofeedback market is expected to reach USD 93.15 million by 2031.
-
What CAGR is the neurofeedback market expected to exhibit by 2031?
The neurofeedback industry is expected to exhibit a CAGR of 6.1% by 2031.
-
Which are the driving factors of the neurofeedback market?
Advancements in neuroimaging technology and rising interest in peak performance are the driving factors of the neurofeedback market.
-
What are the segments of the neurofeedback market?
Based on type the global market can be categorized into slow cortical potential neurofeedback (SCP-NF), low-energy neurofeedback system (LENS), Hemoencephalographic (HEG) neurofeedback and others and based on application the global market can be categorized into ADHD treatment, another clinic uses and non-medical are the segments of the neurofeedback market.